Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-13 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Asthma 3 D001249 ClinicalTrials
Dermatitis, Atopic 3 D003876 ClinicalTrials
Pulmonary Disease, Chronic Obstructive 2 D029424 ClinicalTrials
Idiopathic Pulmonary Fibrosis 2 D054990 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 953400-68-5
ChEMBL CHEMBL1743035
FDA SRS U9JLP7V031
Guide to Pharmacology 7684